Affera’s portfolio includes interventional solutions such as the Affera Prism-1 mapping and navigation platform, designed to help electrophysiologists diagnose heart rhythm issues, and the Sphere-9 cardiac ablation catheter. 

The standard-of-care thinking on TAVR has shifted from getting a valve implanted and managing immediate complications to looking decades down the road and considering the patient's long-term health. 

The Federal Food and Drug Administration (FDA) has amended its emergency use authorizations (EUAs) to include updated booster shots targeting the BA.4 and BA.5 COVID-19 subvariants.

Bibb Allen, MD, FACR, chief medical officer of the American College of Radiology (ACR) Data Science Institute, explains the trend of using AI for the automated detection of stroke on computed tomography (CT) imaging and the need to include radiologists on the stroke care team.

ESC Congress 2022, the annual meeting of the European Society of Cardiology, was jam-packed with eye-opening new research from many of the leading voices in cardiovascular and vascular medicine. These six sessions were just some of the weekend's many highlights. 

"We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic," says Moderna CEO Stéphane Bancel.

The FDA has had a busy month, overseeing the recall of nearly 88,000 implantable cardiac devices, juggling the continued rise of monkeypox cases in the United States and maintaining an active Breakthrough Devices program. This rundown covers some of the agency's biggest moves during that time. 

The new analysis, published in Circulation, confirmed that vaccine-related myocarditis is incredibly rare.